| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/21/1997 | EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases |
| 05/21/1997 | EP0773789A1 Pharmaceutical compositions containing extracted mhc molecules, for stimulation of the immune system |
| 05/21/1997 | EP0773788A1 Improved compositions and methods for chemodenervation using neurotoxins |
| 05/21/1997 | EP0773787A1 HLA binding peptides and their uses |
| 05/21/1997 | EP0684829A4 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof. |
| 05/21/1997 | EP0679187B1 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 05/21/1997 | EP0527821B1 Oxidation resistant thrombomodulin analogs |
| 05/21/1997 | EP0472725B1 Treatment of polycystic ovarian disease |
| 05/21/1997 | CN1150458A Hybrid molecule of formula GM-CSF-L-EPO or EPO-L-GM-CSF for hematopoietic stimulation |
| 05/21/1997 | CN1150434A Platelet growth accelerator |
| 05/21/1997 | CN1150433A Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/21/1997 | CN1150387A Pharmaceutical preparations and medicaments for prevention and treatment of endothelial dysfunction |
| 05/21/1997 | CN1150048A Protein granule composition suitable for intravenous injection |
| 05/21/1997 | CN1150047A Protein granules suitable for intravenous injection |
| 05/21/1997 | CN1034943C Process for preparing cyclic vasoactive peptides |
| 05/20/1997 | US5631394 Pharmaceutically active ceramide-related compounds |
| 05/20/1997 | US5631360 Multistage synthesis, treatment of nucleosides, adding a n-phthaloyl group, deprotecting the hydroxy, tritylation and phosphitylation |
| 05/20/1997 | US5631359 Hairpin ribozymes |
| 05/20/1997 | US5631350 Anti-human influenza virus antibody |
| 05/20/1997 | US5631349 Chimeric monoclonal antibodies recognizing human interleukin-2-receptor |
| 05/20/1997 | US5631348 Protein sequence of the plant toxin gelonin |
| 05/20/1997 | US5631347 Reducing gelation of a fatty acid-acylated protein |
| 05/20/1997 | US5631283 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
| 05/20/1997 | US5631281 N-substituted cycloalkyl and polycycloalkyl α-substituted Trp-Phe- and phenethylamine derivatives |
| 05/20/1997 | US5631241 Wound healing agents of high molecular weight for eyes as antiinflammatory agents |
| 05/20/1997 | US5631236 Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| 05/20/1997 | US5631230 Receptor selective analogues of cholecystokinin-8 |
| 05/20/1997 | US5631229 Method for inactivating gonadotrophs |
| 05/20/1997 | US5631228 Anti-fungal and anti-bacterial histatin-based peptides |
| 05/20/1997 | US5631226 Treatment to reduce edema |
| 05/20/1997 | US5631225 Pharmaceutical formulation |
| 05/20/1997 | US5631224 Use of a peptide |
| 05/20/1997 | US5631223 Cyclic oligopeptides |
| 05/20/1997 | US5631222 Treatment of asthma, angina pectoris, cardiovascular and brain disorders; hypotensive agents |
| 05/20/1997 | US5631221 Pollenosis-inducing polypeptide, process for preparing the same, and uses thereof |
| 05/20/1997 | US5631219 Method of stimulating hematopoiesis with hemoglobin |
| 05/20/1997 | US5631162 Gene expression and dna sequences |
| 05/20/1997 | US5631156 Genetic engineering |
| 05/20/1997 | US5631154 Polypeptides, genetic engineering and assembly of defective viral particles |
| 05/20/1997 | US5631148 A catalytic region, a substrate binder region and a displaceable antisense arm for release of endonuclease cleavage fragments |
| 05/20/1997 | US5631143 K. lactis pyruvate-decarboxylase promoter and use thereof |
| 05/20/1997 | US5631142 Compositions comprising bone morphogenetic protein-2 (BMP-2) |
| 05/20/1997 | US5631133 Transition in transcriptional activation by intracellular hormone receptors at the tumor stage of dermal fibrosarcoma development |
| 05/20/1997 | US5631115 Looped, hairpin ribozyme |
| 05/20/1997 | US5631021 Time release mixtures from oil in water emulsions and drugs |
| 05/20/1997 | US5631020 Method for producing microcapsule |
| 05/20/1997 | US5631019 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 05/20/1997 | US5631011 Hyaluronic acid or derivative; wound healing agents |
| 05/20/1997 | US5631009 Erythrocytes and reaction with antisera and antibodies |
| 05/20/1997 | US5630796 High speed delivery of dry drug particles |
| 05/20/1997 | CA2112355C Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 05/15/1997 | WO1997017460A1 Process for producing phosphatidylserines having polybasic unsaturated fatty acid as side chain |
| 05/15/1997 | WO1997017449A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
| 05/15/1997 | WO1997017448A2 Calcium independent cytosolic phospholipase a2/b enzymes |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997017445A1 Method for treating neurodegenerative diseases using a 1c2 antibody or a fragment or derivative thereof, and corresponding pharmaceutical compositions |
| 05/15/1997 | WO1997017442A1 Flk-1 binding protein |
| 05/15/1997 | WO1997017434A2 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 05/15/1997 | WO1997017433A1 Tissue-specific and target rna-specific ribozymes |
| 05/15/1997 | WO1997017374A1 Recombinant ligands for the human cell membrane antigen cd30 |
| 05/15/1997 | WO1997017372A1 Production of antibodies, and medical uses involving antibodies |
| 05/15/1997 | WO1997017371A1 ISOLATION OF apo(a), COMPOSITIONS, AND METHODS OF USE |
| 05/15/1997 | WO1997017368A1 Cd100 antigen and uses therefor |
| 05/15/1997 | WO1997017367A1 Method of grf peptides synthesis |
| 05/15/1997 | WO1997017365A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
| 05/15/1997 | WO1997017364A1 Peptide derivatives of dolastatin 15 and their use |
| 05/15/1997 | WO1997017363A1 Thrombin inhibitors |
| 05/15/1997 | WO1997017362A1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds |
| 05/15/1997 | WO1997017360A2 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 05/15/1997 | WO1997017358A1 Mammary transforming protein |
| 05/15/1997 | WO1997017090A1 Adenovirus-mediated production of bioactive proteins by mammalian cells and animals |
| 05/15/1997 | WO1997017088A1 Matrix metalloproteinase inhibitors and their therapeutic use |
| 05/15/1997 | WO1997017087A1 Stabilizing formulation for ngf |
| 05/15/1997 | WO1997017086A2 Composition for improving pancreatic function |
| 05/15/1997 | WO1997017085A2 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 05/15/1997 | WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 05/15/1997 | WO1997017083A1 Method for treating obesity and type ii diabetes by adjusting the circadian rhythm of human growth hormone |
| 05/15/1997 | WO1997017081A1 Use of d-arginine and/or l-arginine to remove or block toxic carbonyls and/or dicarbonyls |
| 05/15/1997 | WO1997016983A1 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
| 05/15/1997 | WO1997014792A3 Oligonucleotides with anti-respiratory syncytial virus activity |
| 05/15/1997 | WO1997013781A3 Synthetic peptides that inhibit il-6 activity |
| 05/15/1997 | WO1997012598A3 Dermatological and cosmetic compositions suitable for topical application, having modulating effect on the endogenous ceramide of the skin |
| 05/15/1997 | WO1997007209A3 Receptor |
| 05/15/1997 | WO1997003635A3 P16 expression constructs and their application in cancer therapy |
| 05/15/1997 | WO1997001576A3 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 05/15/1997 | DE19542404A1 Chimeric oligomers with RNA-cleaving activity |
| 05/15/1997 | DE19534763C1 FMR1-verwandtes Protein FMR1-related protein |
| 05/15/1997 | CA2236923A1 Use of d-arginine and/or l-arginine to remove or block toxic carbonyls and/or dicarbonyls |
| 05/15/1997 | CA2235824A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
| 05/15/1997 | CA2235586A1 Thrombin inhibitors |
| 05/15/1997 | CA2235007A1 Novel oligopeptides, the preparation and use thereof |
| 05/15/1997 | CA2234683A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
| 05/15/1997 | CA2234664A1 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 05/14/1997 | EP0773295A2 DNA-based vaccination of fish by immersion |
| 05/14/1997 | EP0773289A2 Asialoglycoprotein receptor derivatives and their use |
| 05/14/1997 | EP0772773A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
| 05/14/1997 | EP0772690A1 Recombinant virus vectors |
| 05/14/1997 | EP0772689A2 Retroviral vectors having a reduced recombination rate |
| 05/14/1997 | EP0772688A1 Sv-40 derived dna constructs comprising exogenous dna sequences |